Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and safety of palbociclib plus fulvestrant in Asian women with hormone receptor-positive (HR plus )/human epidermal growth factor-2 negative (HER2-) metastatic breast cancer (MBC) that progressed on prior endocrine therapy (ET)
- Authors
- Ro, J[Ro, J.]; Im, S[Im, S-A.]; Masuda, N[Masuda, N.]; Im, YH[Im, Y-H.]; Inoue, K[Inoue, K.]; Rai, Y[Rai, Y.]; Nakamura, R[Nakamura, R.]; Kim, JH[Kim, J. H.]; Zhang, K[Zhang, K.]; Giorgetti, C[Giorgetti, C.]; Schnell, P[Schnell, P.]; Bartlett, CH[Bartlett, C. Huang]; Iwata, H[Iwata, H.]
- Issue Date
- Dec-2015
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.26, pp.16 - 16
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 26
- Start Page
- 16
- End Page
- 16
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.